Exclusive: Capricor CEO Talks Exondys Competition
May 03, 2017 at 07:53 AM EDT
Even as it recovered from poor fourth-quarter results, Capricor Therapeutics Inc (NASDAQ: CAPR) pumped a little hope into the world of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.